Literature DB >> 28966464

Cavernous sinus syndrome.

Rakul Nambiar1, Sreejith G Nair1.   

Abstract

Cavernous sinus syndrome (CSS) is a condition characterized by multiple cranial nerve palsies manifesting with ophthalmoplegia, ptosis, and facial sensory loss due to involvement of adjacent cranial nerves. Tumors, trauma, and vascular, infectious, and noninfectious inflammatory disorders have all been described as causes. Lymphomas have been reported to involve the cavernous sinus, both as primary cavernous sinus lymphomas or as secondary lesions. Here, we describe the case of a 63-year-old-man with untreated chronic lymphocytic leukemia (CLL), diagnosed 4 years earlier, who presented with CSS. Our patient underwent standard chemotherapy, but he succumbed to infection during the neutropenic period.

Entities:  

Year:  2017        PMID: 28966464      PMCID: PMC5595394          DOI: 10.1080/08998280.2017.11930227

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  10 in total

1.  Diffuse large B-cell lymphoma within a cavernous hemangioma of the cavernous sinus.

Authors:  Hirofumi Hirano; Yukie Tashiro; Shingo Fujio; Masamichi Goto; Kazunori Arita
Journal:  Brain Tumor Pathol       Date:  2011-07-22       Impact factor: 3.298

2.  Primary malignant lymphoma of the cavernous sinus--case report.

Authors:  H Arimoto; T Shirotani; H Nakau; K Hashizume; Y Sakai; S Matsukuma
Journal:  Neurol Med Chir (Tokyo)       Date:  2000-05       Impact factor: 1.742

Review 3.  Spectrum of neurologic complications in chronic lymphocytic leukemia.

Authors:  Rodrigo Lopes da Silva
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2011-12-21

Review 4.  Cavernous sinus syndrome as the presentation of malignant lymphoma: case report and review of the literature.

Authors:  E S Delpassand; J B Kirkpatrick
Journal:  Neurosurgery       Date:  1988-10       Impact factor: 4.654

5.  Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma.

Authors:  James L Rubenstein; Jane Fridlyand; Lauren Abrey; Arthur Shen; Jon Karch; Endi Wang; Samar Issa; Lloyd Damon; Michael Prados; Michael McDermott; Joan O'Brien; Chris Haqq; Marc Shuman
Journal:  J Clin Oncol       Date:  2007-02-20       Impact factor: 44.544

6.  Fludarabine may induce durable remission in patients with leptomeningeal involvement of chronic lymphocytic leukemia.

Authors:  Stefan Knop; Ulrich Herrlinger; Ulrike Ernemann; Lothar Kanz; Holger Hebart
Journal:  Leuk Lymphoma       Date:  2005-11

7.  Lymphoma with bilateral cavernous sinus involvement in early childhood.

Authors:  M Ceyhan; G Erdem; G Kanra; S Kaya; M Onerci
Journal:  Pediatr Neurol       Date:  1994-02       Impact factor: 3.372

Review 8.  Burkitt's lymphoma with bilateral cavernous sinus and mediastinal involvement in a child.

Authors:  Thierry A G M Huisman; Frank Tschirch; Jacques F L Schneider; Felix Niggli; Ernst Martin-Fiori; Ulrich V Willi
Journal:  Pediatr Radiol       Date:  2003-07-18

Review 9.  Primary cavernous sinus malignant lymphoma treated by gamma knife radiosurgery: case report and review of the literature.

Authors:  H Nakatomi; T Sasaki; S Kawamoto; T Fujimaki; K Furuya; T Kirino
Journal:  Surg Neurol       Date:  1996-09

10.  Primary T-cell lymphoblastic lymphoma of the cavernous sinus.

Authors:  Sarfaraz Sadruddin; L Jeffrey Medeiros; Franco DeMonte
Journal:  J Neurosurg Pediatr       Date:  2010-01       Impact factor: 2.375

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.